BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3957488)

  • 1. Pharmacokinetic studies of nifedipine and digoxin co-administration.
    Koren G; Zylber-Katz E; Granit L; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions of digoxin with nifedipine and diltiazem].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):467-9. PubMed ID: 2277790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of propafenone on the pharmacokinetics of digoxin administered orally: a study in healthy volunteers].
    Cardaioli P; Compostella L; De Domenico R; Papalia D; Zeppellini R; Libardoni M; Pulido E; Cucchini F
    G Ital Cardiol; 1986 Mar; 16(3):237-40. PubMed ID: 3732716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-interaction between nifedipine and digoxin.
    Pedersen KE; Madsen JL; Klitgaard NA; Kjoer K; Hvidt S
    Dan Med Bull; 1986 Apr; 33(2):109-10. PubMed ID: 3709238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of an interaction between tigecycline and digoxin in healthy men.
    Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
    Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers.
    Ding R; Tayrouz Y; Riedel KD; Burhenne J; Weiss J; Mikus G; Haefeli WE
    Clin Pharmacol Ther; 2004 Jul; 76(1):73-84. PubMed ID: 15229466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose kinetics of digoxin in neonates.
    Collins-Nakai RL; Schiff D; Ng PK
    Pediatr Pharmacol (New York); 1985; 5(2):117-22. PubMed ID: 4047750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of amiodarone on oral digoxin bioavailability in healthy volunteers.
    Maragno I; Santostasi G; Gaion RM; Paleari C
    Int J Clin Pharmacol Res; 1984; 4(2):149-53. PubMed ID: 6469441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic basis of nifedipine-digoxin interaction: a commentary.
    Kokwaro GO
    East Afr Med J; 1995 Oct; 72(10):684-7. PubMed ID: 8904054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study.
    Boje KM; Dolce JA; Fung HL
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):219-26. PubMed ID: 6515116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.
    Ravis WR; Pedersoli WM; Turco JD
    Am J Vet Res; 1987 Aug; 48(8):1244-9. PubMed ID: 3631715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variations in the pharmacokinetics, tissue distribution and urinary excretion of nifedipine after a single oral administration to rats.
    Cao QR; Kim TW; Choi JS; Lee BJ
    Biopharm Drug Dispos; 2005 Dec; 26(9):427-37. PubMed ID: 16217814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of age on the pharmacokinetic parameters of digoxin].
    Korkushko OV; Orlov PA; Bezverkhaia IS; Belyĭ AA
    Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.